Maria Labrador

3PUBLICATIONS
13CO-AUTHORS
Molecular targetsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 13, 2026
MDM2 Drives Proteasome Inhibitor Resistance and Represents a TP53-Independent Therapeutic Vulnerability in Multiple Myeloma.

|Oct 16, 2024
IDH2 Inhibitors Gain a Wildcard Status in the Cancer Therapeutics Competition.

Roberto Piva, Nariman Gharari, Maria Labrador

|May 16, 2023
Euchromatic Histone Lysine Methyltransferase 2 Inhibition Enhances Carfilzomib Sensitivity and Overcomes Drug Resistance in Multiple Myeloma Cell Lines.

Elisabetta Mereu, Damiano Abbo, Tina Paradzik

Pageof 1

Frequent Collaborators

3 joint publications

Roberto Piva

2 joint publications

Tina Paradzik

2 joint publications

Domenica Ronchetti

2 joint publications

Veronica Manicardi